|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-6-10
|
|
pubmed:abstractText |
Adequate monitoring of cystic fibrosis lung disease is difficult. CF exacerbation offers a unique setting to test the utility of biomarkers in the assessment of changing airways inflammation. We hypothesised that levels of calprotectin in sputum (and serum) would change informatively following treatment of an exacerbation.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1873-5010
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
193-8
|
|
pubmed:meshHeading |
pubmed-meshheading:20299288-Adolescent,
pubmed-meshheading:20299288-Adult,
pubmed-meshheading:20299288-Biological Markers,
pubmed-meshheading:20299288-Cystic Fibrosis,
pubmed-meshheading:20299288-Disease Progression,
pubmed-meshheading:20299288-Female,
pubmed-meshheading:20299288-Humans,
pubmed-meshheading:20299288-Leukocyte L1 Antigen Complex,
pubmed-meshheading:20299288-Male,
pubmed-meshheading:20299288-Middle Aged,
pubmed-meshheading:20299288-Sputum,
pubmed-meshheading:20299288-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Sputum and serum calprotectin are useful biomarkers during CF exacerbation.
|
|
pubmed:affiliation |
School of Molecular and Clinical Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK. r.d.gray@ed.ac.uk <r.d.gray@ed.ac.uk>
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
